CSS
LJPC

Cubist Systematic Strategies’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cubist Systematic Strategies’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,218
Closed -$69K – 3246
2021
Q1 		$69K Buy
+16,218
New +$89.4K ﹤0.01% 2703
2020
Q1 		– Sell
-24,971
Closed -$98K – 2673
2019
Q4 		$98K Buy
24,971
+11,850
+90% +$70K ﹤0.01% 2194
2019
Q3 		$115K Buy
+13,121
New +$124K ﹤0.01% 1907
2019
Q1 		– Sell
-9,548
Closed -$90K – 2561
2018
Q4 		$90K Buy
9,548
+9,499
+19,386% +$143K ﹤0.01% 1776
2018
Q3 		$1K Buy
+49
New +$1.28K ﹤0.01% 1854

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's LJPC Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 16,218 shares — an estimated $69K sold.

Cubist Systematic Strategies first reported a position in LJPC in Q3 2018 and held it in 5 quarters. The position peaked at $115K in Q3 2019. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Cubist Systematic Strategies reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 16,218 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $69K.
  • Cubist Systematic Strategies first reported a position in La Jolla Pharmaceutical Company in Q3 2018 and held it in 5 quarters.
  • Cubist Systematic Strategies's La Jolla Pharmaceutical Company position peaked at $115K in Q3 2019.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.